Found 9709 bookmarks
Newest
Current and future microbiome-based therapies in inflammatory bowel disease - PubMed
Current and future microbiome-based therapies in inflammatory bowel disease - PubMed
The body of evidence supporting the use of IMT in IBD is growing. The lack of a standardized protocol impedes its application beyond clinical trials. Further research is needed to identify patient profile and disease phenotypes that benefit from IMT, to delineate key donor characteristics, optimize …
·pubmed.ncbi.nlm.nih.gov·
Current and future microbiome-based therapies in inflammatory bowel disease - PubMed
A decade of insight: bibliometric analysis of gut microbiota's role in osteoporosis (2014-2024) - PubMed
A decade of insight: bibliometric analysis of gut microbiota's role in osteoporosis (2014-2024) - PubMed
This is the first bibliometric analysis of gut microbiota in osteoporosis. We explored current research status in recent years and identified frontiers and hot spots in this research field. We investigate the impact of gut microbiome dysregulation and its associated inflammation on OP progression, a …
·pubmed.ncbi.nlm.nih.gov·
A decade of insight: bibliometric analysis of gut microbiota's role in osteoporosis (2014-2024) - PubMed
Current and future microbiome-based therapies in inflammatory bowel disease - PubMed
Current and future microbiome-based therapies in inflammatory bowel disease - PubMed
The body of evidence supporting the use of IMT in IBD is growing. The lack of a standardized protocol impedes its application beyond clinical trials. Further research is needed to identify patient profile and disease phenotypes that benefit from IMT, to delineate key donor characteristics, optimize …
·pubmed.ncbi.nlm.nih.gov·
Current and future microbiome-based therapies in inflammatory bowel disease - PubMed
Rise to the Challenge: Master the Management of Clostridioides difficile Infection - PubMed
Rise to the Challenge: Master the Management of Clostridioides difficile Infection - PubMed
Clostridioides difficile infection (CDI) is a significant public health challenge in the developed world. Although previously CDI was primarily a health care-acquired infection, there are now rising numbers of community-acquired cases in patients without traditional risk factors, such as antibiotic …
·pubmed.ncbi.nlm.nih.gov·
Rise to the Challenge: Master the Management of Clostridioides difficile Infection - PubMed
Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation - PubMed
Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation - PubMed
Clostridioides difficile results in upward of 250,000 infections and 12,000 deaths annually in the United States. Community-acquired infections continue to rise, and recurrent disease is common, emphasizing a vital need to understand C. difficile pathogenesis. C. difficile undou …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation - PubMed
Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota - PubMed
Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota - PubMed
Inflammatory bowel disease (IBD) is a recurrent inflammatory condition affecting the gastrointestinal tract, and its clinical treatment remains suboptimal. Probiotics have shown effectiveness in alleviating dextran sulfate sodium salt (DSS)-induced colitis, exhibiting strain-specific anti-inflammato …
·pubmed.ncbi.nlm.nih.gov·
Bifidobacterium bifidum Ameliorates DSS-Induced Colitis in Mice by Regulating Microbial Metabolome and Targeting Gut Microbiota - PubMed
Dietary α-linolenic acid supplementation enhances resistance to Salmonella Typhimurium challenge in chickens by altering the intestinal mucosal barrier integrity and cecal microbes - PubMed
Dietary α-linolenic acid supplementation enhances resistance to Salmonella Typhimurium challenge in chickens by altering the intestinal mucosal barrier integrity and cecal microbes - PubMed
Salmonella is an important foodborne pathogen. Given the ban on the use of antibiotics during the egg-laying period in China, finding safe and effective alternatives to antibiotics to reduce Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) infections in chickens is essential …
·pubmed.ncbi.nlm.nih.gov·
Dietary α-linolenic acid supplementation enhances resistance to Salmonella Typhimurium challenge in chickens by altering the intestinal mucosal barrier integrity and cecal microbes - PubMed
Implementation of multifaceted diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital - PubMed
Implementation of multifaceted diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital - PubMed
Multifaceted DS involving multidisciplinary specialists was effective in improving CD testing, suggesting that appropriate testing can contribute to diagnosing CDI accurately.
·pubmed.ncbi.nlm.nih.gov·
Implementation of multifaceted diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital - PubMed
Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging - PubMed
Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging - PubMed
The global rise in life expectancy corresponds with a delay in childbearing age among women. Ovaries, seen as the chronometers of female physiological aging, demonstrate features of sped up aging, evidenced by the steady decline in both the quality and quantity of ovarian follicles from birth. The m …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging - PubMed
The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study - PubMed
The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study - PubMed
Decreased utilization of fluoroquinolones in two Québec hospitals was associated with a decrease in the incidence of HA-CDI and a genotype shift from NAP1/027 to non-NAP1/027 strains.
·pubmed.ncbi.nlm.nih.gov·
The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study - PubMed
Treating Helicobacter pylori and Recurrent Clostridioides difficile Coinfection: A Delicate Balance in Management and a Need for Guidelines - PubMed
Treating Helicobacter pylori and Recurrent Clostridioides difficile Coinfection: A Delicate Balance in Management and a Need for Guidelines - PubMed
Treating Helicobacter pylori and Clostridioides difficile coinfection presents a challenging clinical dilemma. Treating H. pylori may increase the risk of C. difficile, and antibiotics generally have been shown to increase the risk of C. difficile infection/recurre …
·pubmed.ncbi.nlm.nih.gov·
Treating Helicobacter pylori and Recurrent Clostridioides difficile Coinfection: A Delicate Balance in Management and a Need for Guidelines - PubMed
Administering Live Biotherapeutic Products
Administering Live Biotherapeutic Products
With the addition of live biotherapeutic products, a provider offers some insights into delivery and treatment considerations.
·contagionlive.com·
Administering Live Biotherapeutic Products
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Pune, Feb. 19, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Clostridium Difficile Infections...
·news.google.com·
Clostridium Difficile Infections Treatment Market is set to Reach US$ 1,727.1 million at a CAGR of 6.8% from the forecast period 2023 to 2031 | Growth Plus Reports
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization - PubMed
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization - PubMed
This study revealed the hypoglycemic and hepatoprotective effect of CP by regulating gut microbiota composition and PPARα subcellular localization, highlighting its potential for therapeutic candidate for metabolic disorders.
·pubmed.ncbi.nlm.nih.gov·
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization - PubMed
Tubo-ovarian abscess caused by Clostridioides difficile after eight months of surgery : case report and review of extraintestinal abdominal abscess cases - PubMed
Tubo-ovarian abscess caused by Clostridioides difficile after eight months of surgery : case report and review of extraintestinal abdominal abscess cases - PubMed
We present a case of tubo-ovarian abscess (TOA) caused by Clostridioides difficile (CD) in a 43-year-old female. Despite lacking a history of sexually transmitted diseases, the patient had undergone paraovarian cystectomy nine months before admission. Transvaginal ultrasonography performed eight mon …
·pubmed.ncbi.nlm.nih.gov·
Tubo-ovarian abscess caused by Clostridioides difficile after eight months of surgery : case report and review of extraintestinal abdominal abscess cases - PubMed
Fight or flee, a vital choice for Clostridioides difficile - PubMed
Fight or flee, a vital choice for Clostridioides difficile - PubMed
Clostridioides difficile is a leading cause of healthcare-associated infections, causing billions of economic losses every year. Its symptoms range from mild diarrhea to life-threatening damage to the colon. Transmission and recurrence of C. difficile infection (CDI) are mediated by th …
·pubmed.ncbi.nlm.nih.gov·
Fight or flee, a vital choice for Clostridioides difficile - PubMed
Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond - PubMed
Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond - PubMed
The human microbiome, particularly the gut microbiome, has emerged as a central determinant of health and disease. Dysbiosis, an imbalance in the microbial composition of the gut, is associated with a variety of metabolic and other diseases, highlighting the potential for microbiota-targeted treatme …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond - PubMed
The J-Man Chronicles: Doodie-DoorDash. Freshly Frozen Feces, from
The J-Man Chronicles: Doodie-DoorDash. Freshly Frozen Feces, from
Here's something you won't find on Amazon. Nor is it at the duty-free shops in airports – packaged frozen feces for consumption. Believe it or not, a company called Human Microbes has been buying,
·news.google.com·
The J-Man Chronicles: Doodie-DoorDash. Freshly Frozen Feces, from
Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation - PubMed
Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation - PubMed
Systemic lupus erythematosus (SLE) is characterized by a systemic dysfunction of the innate and adaptive immune systems, leading to an attack on healthy tissues of the body. During the development of SLE, pathogenic features, such as the formation of autoantibodies to self-nuclear antigens, caused t …
·pubmed.ncbi.nlm.nih.gov·
Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation - PubMed
Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network meta-analysis - PubMed
Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network meta-analysis - PubMed
Currently, there are increasingly diverse treatment modalities for chronic functional constipation (CFC). This study aims to compare the relative efficacy and safety of chemical drugs, fecal microbiota transplantation (FMT), probiotics, dietary fiber, and acupuncture in the treatment of patients wit …
·pubmed.ncbi.nlm.nih.gov·
Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network meta-analysis - PubMed
Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice - PubMed
Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice - PubMed
Metabolic syndrome encompasses amongst other conditions like obesity and type-2 diabetes and is associated with gut microbiome (GM) dysbiosis. Fecal microbiota transplantation (FMT) has been explored to treat metabolic syndrome by restoring the GM; however, concerns on accidentally transferring path …
·pubmed.ncbi.nlm.nih.gov·
Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice - PubMed
From Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke - PubMed
From Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke - PubMed
Stroke, a neurological disorder, is intricately linked to the gut microbiota, influencing microbial composition and elevating the risk of ischemic stroke. The neuroprotective impact of short-chain fatty acids (SCFAs) derived from dietary fiber fermentation contrasts with the neuroinflammatory effect …
·pubmed.ncbi.nlm.nih.gov·
From Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke - PubMed
Fecal Microbiota Transplantation in a Domestic Ferret Suffering from Chronic Diarrhea and Maldigestion-Fecal Microbiota and Clinical Outcome: A Case Report - PubMed
Fecal Microbiota Transplantation in a Domestic Ferret Suffering from Chronic Diarrhea and Maldigestion-Fecal Microbiota and Clinical Outcome: A Case Report - PubMed
This case report describes the effects of fecal microbiota transplantation (FMT) administered via enema in a 4-year-old spayed, champagne Domestic Ferret (Mustela putorius furo) with chronic diarrhea, maldigestion and weight loss. We aimed to establish a protocol for FMT as a novel therapeuti …
·pubmed.ncbi.nlm.nih.gov·
Fecal Microbiota Transplantation in a Domestic Ferret Suffering from Chronic Diarrhea and Maldigestion-Fecal Microbiota and Clinical Outcome: A Case Report - PubMed